Craneware secures US hospital contract
The contract will see Craneware’s Pharmacy ChargeLink solution roll out to the 12 facilities across the network from October 2018. Craneware expects the contract to deliver more than
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More XThe contract will see Craneware’s Pharmacy ChargeLink solution roll out to the 12 facilities across the network from October 2018. Craneware expects the contract to deliver more than
On June 5, 2018, Judge Richard G. Andrews of the U.S. District Court for the District of Delaware issued a permanent injunction against Natus and anyone acting in active concert or participation with
In its inspection in 2014, the US regulator found that the company’s devices are adulterated and were not in conformity with the good manufacturing practice requirements. In the
FMI is engaged in the development, manufacture and sale of genomic analysis diagnostics for solid and circulating cancers. Together, Roche and FMI will use expertise in genomics and
The company has closed an initial tranche of funding in a financing round, expected to reach $30m, led by Savitr Capital and other existing investors. Ancora Heart will
NeuralBot is a robotic assistance system, which holds capacity to automatically adjust orientation and position of its ultrasound products under a healthcare professional’s assistance. The robotic assistance system,
DiLumen Is is a sterile, single-use, disposable and monopolar electrosurgical device for cutting, dissecting, and cauterizing tissue within the digestive tract during endoscopic procedures. DiLumen Is is the
Isatuximab is an investigational anti-CD38 monoclonal antibody, which is currently under clinical development to treat newly diagnosed, relapsed and refractory MM. Sanofi will use daptive’s NGS-based clonoSEQ assay
Counsyl operates advanced clinical laboratory, which provides Foresight carrier screen, Prelude prenatal screen and Reliant cancer screen tests, as well as supporting services through Counsyl Complete suite of
The study showed that Idylla EGFR mutation test produced a result in 80% of the EGFR samples whose assessment was unsuccessful with NGS. The study concluded that the